Analysis of the humoral and cellular immune response to the BBV152/Covaxin inactivated vaccine reveals that it induces a robust SARS-CoV-2-specific immune memory that persists for at least 6 months and shows somewhat reduced efficiency against SARS-CoV-2 variants.
- Rajesh Vikkurthi
- Asgar Ansari
- Nimesh Gupta